Moderna (MRNA) shares have been under pressure lately, slipping around 8% over the past month. Investors continue to weigh up ...
TipRanks on MSN
Moderna price target lowered to $28 from $30 at Berenberg
Berenberg lowered the firm’s price target on Moderna (MRNA) to $28 from $30 and keeps a Hold rating on the shares. The firm thinks BioNTech’s ...
Moderna, Inc. (MRNA) is a biotechnology firm based in Cambridge, Massachusetts, that focuses on mRNA technology to create ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback